OncoMed Pharmaceuticals Inc Deferred Tax Assets, Net of Valuation Allowance
OncoMed Pharmaceuticals Inc had Deferred Tax Assets, Net of Valuation Allowance of $10.30 million as of 2013-12-31, per its 10-K filed 2015-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2015-03-12
- 2013-12-31: Deferred Tax Assets, Net of Valuation Allowance $10.30M; Deferred Tax Assets, Net of Valuation Allowance as first filed $10.33M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2013-12-31 | $10.30M 10-K · filed 2015-03-12 | $10.33M 10-K · filed 2014-03-18 |